For the quarter ending 2026-03-31, AIFF made $485K in revenue. -$2,094K in net income. Net profit margin of -431.75%.
| Income Statement | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Revenue | 485 | 412 | 388 | 299 |
| Cost of goods sold | 264 | 230 | 242 | 25 |
| Gross profit | 221 | 182 | 146 | 274 |
| Research and development expenses | 424 | 456 | 378 | 336 |
| Selling and marketing expenses | 141 | 128 | 265 | 199 |
| General and administration expenses | 1,666 | 2,000 | 2,007 | 1,373 |
| Impairment of assets | - | 99 | 152 | - |
| Total operating expenses | 2,231 | 2,683 | 2,802 | 1,908 |
| Operating loss | -2,010 | -2,501 | -2,656 | -1,634 |
| Interest and bank fees | 7 | 122* | 10 | 15 |
| Interest income | 14 | 1* | 29 | 30 |
| Unrealized loss (gain) on foreign exchange | -1 | 1* | - | -7 |
| Other income (expense), net | 0 | -1 | -2 | -203 |
| Change in derivative fair value | 0 | -533* | - | 0 |
| Gain on settlement | 0 | 677* | - | 0 |
| Total other income (expense) | 6 | 22 | 17 | -195 |
| Loss before income tax | -2,004 | -2,479 | -2,639 | -1,829 |
| Income tax provision | 0 | 1 | - | 4 |
| Net loss and comprehensive loss | -2,004 | -2,480* | -2,639 | -1,833 |
| Deemed dividend on warrant inducement | -90 | -4,649* | - | 0 |
| Net loss and comprehensive loss attributable to common stockholders | -2,094 | -7,129 | -2,639 | -1,833 |
| Basic EPS | -0.13 | -0.522 | -0.2 | -0.14 |
| Diluted EPS | - | - | -0.2 | - |
| Basic Average Shares | 16,227,346 | 13,650,589 | 13,497,668 | 12,668,550 |
| Diluted Average Shares | - | - | 13,497,668 | - |
FIREFLY NEUROSCIENCE, INC. (AIFF)
FIREFLY NEUROSCIENCE, INC. (AIFF)